TeraLumen - About the company
TeraLumen is a funded company based in Chennai (India), founded in 2019 by Shaumik Ray. It operates as a Provider of terahertz-based non-destructive testing systems for industrial and biomedical applications. TeraLumen has raised an undisclosed amount in funding from Pfizer. The company has 162 active competitors, including 41 funded and 13 that have exited. Its top competitors include companies like Scholar Rock, SamanTree Medical and Lucida Medical.
Company Details
Provider of terahertz-based non-destructive testing systems for industrial and biomedical applications. The company delivers testing solutions and research systems utilizing terahertz technology. These systems cater to diverse sectors, offering non-invasive inspection methods. The company provides hardware, software, and accessories for research and industrial applications.
- Website
- www.teralumensolutions.com/
- Email ID
- *****@teralumensolutions.com
- Phone Number
- +91 **********
- Registered Address
- Plot No. 647, 655, Duplex-03, Sambit Residency, Phase-1, GGP Colony, G.G.P.Colony, Khorda, Bhubaneswar, Orissa, India, 751025
Key Metrics
Founded Year
2019
Location
Chennai, India
Stage
Funding Raised
Latest Funding Round
Ranked
23rd among 162 active competitors
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2025
Employee Count
21 as on Sep 30, 2026
Similar Companies
Legal entities associated with TeraLumen
TeraLumen is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
TERALUMEN SOLUTIONS PRIVATE LIMITED CIN: U29309OD2019PTC049160 , India, Active | Jul 22, 2019 | 0 - ₹10 Cr (As on Mar 31, 2025) | - |
Sign up to download TeraLumen's company profile
TeraLumen's funding and investors
TeraLumen has raised funding over 3 rounds. Its first funding round was on Dec 02, 2020. Its latest funding round was a Grant (prize money) round on Sep 12, 2022 for $*****. 2 investors participated in its latest round. TeraLumen has 7 institutional investors.
Here is the list of recent funding rounds of TeraLumen:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 12, 2022 | 4739114 | Grant (prize money) | 4384548 | 3384531 | 1079129 | 4945050 |
Oct 2021 | 9794989 | Grant (prize money) | 4167592 | 7382426 | 2439705 | |
Dec 02, 2020 | 1439813 | Grant (prize money) | 6837750 | 6669498 | 4220819 |
View details of TeraLumen's funding rounds and investors
TeraLumen's founders and board of directors
Founder? Claim ProfileThe founders of TeraLumen is Shaumik Ray. Saurabh Kochhar is the CEO of TeraLumen.
Here are the details of TeraLumen's key team members:
- Shaumik Ray: Former Co-Founder of TeraLumen.
TeraLumen's Board of Directors
TeraLumen's board has 3 active members. George Thomas and Jyotirmayee Jyotirmayee Dash are part of team and Balasubrahmanyam Pesala is independent board member.Here is the list of TeraLumen's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 7y 2m | |
Investor | - | Current | 2y 7m | |
Independent board member | - | Current | 2y 7m |
View details of TeraLumen's Founder profiles and Board Members
TeraLumen's employee count trend
TeraLumen has 21 employees as of Sep 26. Here is TeraLumen's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
TeraLumen's Competitors and alternates
Top competitors of TeraLumen include Scholar Rock, SamanTree Medical and Lucida Medical. Here is the list of Top 10 competitors of TeraLumen, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Scholar Rock 2012, Cambridge (United States), Public | Developer of Antibody-based drugs for the treatment of primary myopathies | $103M | 61/100 | |
2nd | SamanTree Medical 2014, Lausanne (Switzerland), Series C | Developer of digital microscopy system for high-resolution imaging of tissue | $57.5M | 61/100 | |
3rd | Lucida Medical 2019, Cambridge (United Kingdom), Series A | Developer of MRI-based cancer screening technology using artificial intelligence (AI) | $11.5M | 59/100 | |
4th | TeraView 2001, Cambridge (United Kingdom), Public | Manufacturer of terahertz imaging systems for industrial inspection and analysis | $21.5M | 55/100 | |
5th | Developer of diagnostic instruments, reagents, and related software | - | - | 55/100 | |
6th | Provider of magnetic probe based device of treatment of multiple cancer | $17.5M | 53/100 | ||
7th | Developer of therapy-assist CT system for minimally invasive interventions | $8.4M | 52/100 | ||
8th | Provider of an AI-enabled immunotherapy based tumor diagnostic platform | $38.2M | 52/100 | ||
9th | Imagion Biosystems 2016, Albuquerque (United States), Public | Developer of molecular magnetic resonance imaging technology for cancer detection | - | 50/100 | |
10th | Perfint Healthcare 2005, Chennai (India), Series D | Developer of solutions for image-guided interventional procedures | $65.6M | 50/100 | |
23rd | Provider of terahertz-based non-destructive testing systems for industrial and biomedical applications | - | 39/100 |
Looking for more details on TeraLumen's competitors? Click here to see the top ones
TeraLumen's Investments and acquisitions
TeraLumen has made no investments or acquisitions yet.
Reports related to TeraLumen
Here is the latest report on TeraLumen's sector:
News related to TeraLumen
•
Are you a Founder ?
FAQs about TeraLumen
Explore our recently published companies
- Sagtur Sistemas - Brazil based, 2020 founded, Unfunded company
- SafariSync - Nairobi based, Unfunded company
- Sadler Bonn - Germany based, 1909 founded, Unfunded company
- Sadai - Dhaka based, Unfunded company
- Regio Kv - Estonia based, Unfunded company
- Reaching Higher Tree Care - United States based, Unfunded company
